Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Veldman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|November 23, 2019
Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphomaJohanna Veldman, Lydia Visser, Anke van den Berg, et al.
British Journal of Haematology|February 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphomaJohanna Veldman, Zainab N D Alsada, Anke van den Berg, et al.
Blood|June 27, 2020
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, et al.
Plos One|July 10, 2020
Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 productionAnouk von Borstel, Wayel H Abdulahad, Gerjan Dekkema, et al.
Oncoimmunology|February 3, 2022
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphomaJohanna Veldman, Jessica Rodrigues Plaça, Lauren Chong, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Leukemia|September 29, 2021
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphomaMaria A Garcia-Marquez, Martin Thelen, Sarah Reinke, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Cancer Discovery|December 21, 2019
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin LymphomaTomohiro Aoki, Lauren C Chong, Katsuyoshi Takata, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|November 23, 2019
Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphomaJohanna Veldman, Lydia Visser, Anke van den Berg, et al.
British Journal of Haematology|February 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphomaJohanna Veldman, Zainab N D Alsada, Anke van den Berg, et al.
Blood|June 27, 2020
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, et al.
Plos One|July 10, 2020
Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 productionAnouk von Borstel, Wayel H Abdulahad, Gerjan Dekkema, et al.
Oncoimmunology|February 3, 2022
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphomaJohanna Veldman, Jessica Rodrigues Plaça, Lauren Chong, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Leukemia|September 29, 2021
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphomaMaria A Garcia-Marquez, Martin Thelen, Sarah Reinke, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Cancer Discovery|December 21, 2019
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin LymphomaTomohiro Aoki, Lauren C Chong, Katsuyoshi Takata, et al.
Pageof 1